CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 552 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01386684
NCT01386684N/ACompleted
CompareCT.gov

Canadian Real-Life Evaluation of the Effectiveness of Lupron in the Management of Prostate Cancer (CRONOS)

AbbVie (prior sponsor, Abbott)·observational·Posted Jul 1, 2011·Updated Dec 13, 2018

In Brief

An observational study for Prostate Cancer. Completed, enrolled 552 participants.

Detailed Summary

The purpose of this study is to evaluate the Canadian Real Life Evaluation of the Effectiveness of Lupron in the Management of Prostate Cancer.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
Countries--
CollaboratorsJSS Medical Research Inc., CMX Research

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 1, 2011
Enrollment StartJun 28, 2011
Primary CompletionSep 8, 2016
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 15.0 years ago